These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 15918575

  • 1. [A trial of biweekly paclitaxel administration in consideration of QOL for advanced or recurrent gynecologic cancer].
    Fushiki H, Yoshimoto H, Ikoma T, Ota S.
    Gan To Kagaku Ryoho; 2005 May; 32(5):691-3. PubMed ID: 15918575
    [Abstract] [Full Text] [Related]

  • 2. [Practical use of taxol-based chemotherapy for poor compliance gynecologic cancers in Japanese woman].
    Mitsui M, Takashi K, Imai K.
    Gan To Kagaku Ryoho; 2003 Mar; 30(3):383-9. PubMed ID: 12669398
    [Abstract] [Full Text] [Related]

  • 3. [Patient compliance and the quality of life are well maintained in weekly paclitaxel and carboplatin therapy for advanced gynecologic cancers in Japanese women].
    Kurihara M, Sakamoto H, Ohta Y, Takami T, Takami M, Nakayama Y, Murata H, Ohtani K, Masaoka N, Yamamoto T, Satoh K.
    Gan To Kagaku Ryoho; 2001 Jan; 28(1):55-61. PubMed ID: 11201381
    [Abstract] [Full Text] [Related]

  • 4. Biweekly pegylated liposomal doxorubicin as second-line treatment in patients with relapsed ovarian cancer after failure of platinum and paclitaxel: results from a multi-center phase II study of the NOGGO.
    Oskay-Oezcelik G, Koensgen D, Hindenburg HJ, Klare P, Schmalfeldt B, Lichtenegger W, Chekerov R, Al-Batran SE, Neumann U, Sehouli J, Ovarian Cancer Study Group of the North-Eastern Germany Society of Gynecological Oncology (NOGGO).
    Anticancer Res; 2008 Jan; 28(2B):1329-34. PubMed ID: 18505074
    [Abstract] [Full Text] [Related]

  • 5. Second-line chemotherapy with biweekly paclitaxel after failure of fluoropyrimidine-based treatment in patients with advanced or recurrent gastric cancer: a report from the gastrointestinal oncology group of the Tokyo cooperative oncology group, TCOG GC-0501 trial.
    Koizumi W, Akiya T, Sato A, Yamaguchi K, Sakuyama T, Nakayama N, Tanabe S, Higuchi K, Sasaki T, Sekikawa T, Tokyo Cooperative Oncology Group (TCOG GI Group).
    Jpn J Clin Oncol; 2009 Nov; 39(11):713-9. PubMed ID: 19812061
    [Abstract] [Full Text] [Related]

  • 6. Randomized phase III trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer: a gynecologic cancer intergroup trial of the AGO-OVAR and GINECO.
    Pfisterer J, Weber B, Reuss A, Kimmig R, du Bois A, Wagner U, Bourgeois H, Meier W, Costa S, Blohmer JU, Lortholary A, Olbricht S, Stähle A, Jackisch C, Hardy-Bessard AC, Möbus V, Quaas J, Richter B, Schröder W, Geay JF, Lück HJ, Kuhn W, Meden H, Nitz U, Pujade-Lauraine E, AGO-OVAR, GINECO.
    J Natl Cancer Inst; 2006 Aug 02; 98(15):1036-45. PubMed ID: 16882940
    [Abstract] [Full Text] [Related]

  • 7. [Clinical study on the efficacy of weekly paclitaxel administration for platinum-resistant epithelial ovarian carcinoma].
    Fujii K, Takano M, Okamoto S, Sasaki N, Kita T, Kikuchi Y.
    Gan To Kagaku Ryoho; 2004 Dec 02; 31(13):2141-4. PubMed ID: 15628759
    [Abstract] [Full Text] [Related]

  • 8. Phase II study of biweekly paclitaxel and cisplatin combination chemotherapy in advanced gastric cancer: Korea Japan Collaborative Study Group Trial.
    Kim YH, Yamaguchi K, Bang YJ, Takiuchi H, Kang WK, Sato A, Kang YK, Sakamoto J, Abe C, Sakata Y.
    Jpn J Clin Oncol; 2007 Jul 02; 37(7):501-8. PubMed ID: 17673470
    [Abstract] [Full Text] [Related]

  • 9. Randomized study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group comparing quality of life in patients with ovarian cancer treated with cisplatin/paclitaxel versus carboplatin/paclitaxel.
    Greimel ER, Bjelic-Radisic V, Pfisterer J, Hilpert F, Daghofer F, du Bois A, Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
    J Clin Oncol; 2006 Feb 01; 24(4):579-86. PubMed ID: 16446330
    [Abstract] [Full Text] [Related]

  • 10. A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer. A Multicentre Italian Trial in Ovarian cancer (MITO-5) study.
    Pignata S, Breda E, Scambia G, Pisano C, Zagonel V, Lorusso D, Greggi S, De Vivo R, Ferrandina G, Gallo C, Perrone F.
    Crit Rev Oncol Hematol; 2008 Jun 01; 66(3):229-36. PubMed ID: 18243011
    [Abstract] [Full Text] [Related]

  • 11. [Combination chemotherapy study of biweekly paclitaxel and S-1 administration in patients with advanced gastric cancer].
    Hokita S, Aikou T, Ishigami S, Miyazono F, Nakajo A, Uenosono Y, Hamanoue M, Aridome K, Natsugoe S.
    Gan To Kagaku Ryoho; 2006 Jun 01; 33 Suppl 1():95-8. PubMed ID: 16897981
    [Abstract] [Full Text] [Related]

  • 12. [A case of recurrent stomach cancer treated with 5-fluorouracil responding to weekly paclitaxel therapy].
    Fukuda Y, Fujio N, Ihara T, Terakura M, Takatori H, Tsukazaki T, Koyama I, Tsukazaki Y, Osugi H.
    Gan To Kagaku Ryoho; 2004 Sep 01; 31(9):1419-22. PubMed ID: 15446569
    [Abstract] [Full Text] [Related]

  • 13. Quality of life in ovarian cancer patients: comparison of paclitaxel plus cisplatin, with cyclophosphamide plus cisplatin in a randomized study.
    Bezjak A, Tu D, Bacon M, Osoba D, Zee B, Stuart G, Roy JA, Piccart M, Eisenhauer E.
    J Clin Oncol; 2004 Nov 15; 22(22):4595-603. PubMed ID: 15466785
    [Abstract] [Full Text] [Related]

  • 14. [Consecutive low-dose cisplatin-based chemotherapy for gynecologic malignancies].
    Shimizu Y.
    Gan To Kagaku Ryoho; 1997 Feb 15; 24(4):431-8. PubMed ID: 9063480
    [Abstract] [Full Text] [Related]

  • 15. [Weekly paclitaxel infusion in patients with recurrent ovarian cancer--a pilot study].
    Kawagoe H, Kawata T, Nishio S, Shimomura T, Fujiyoshi K, Ishimatsu J, Tsunawaki A.
    Gan To Kagaku Ryoho; 2003 Jan 15; 30(1):151-4. PubMed ID: 12557722
    [Abstract] [Full Text] [Related]

  • 16. Weekly administration of topotecan-paclitaxel as second-line treatment in ovarian cancer.
    Stathopoulos GP, Malamos NA, Aravantinos G, Rigatos S, Christodoulou Ch, Stathopoulos J, Skarlos D.
    Cancer Chemother Pharmacol; 2007 Jun 15; 60(1):123-8. PubMed ID: 17111119
    [Abstract] [Full Text] [Related]

  • 17. A pilot study of weekly paclitaxel administration for patients with relapsed cervical cancer after heavy medication.
    Terauchi F, Nagashima T, Kobayashi Y, Yamamoto Y, Moritake T, Seiki T, Ogura H.
    Gan To Kagaku Ryoho; 2005 May 15; 32(5):641-4. PubMed ID: 15918564
    [Abstract] [Full Text] [Related]

  • 18. Combination therapy with pegylated liposomal doxorubicin and carboplatin in gynecologic malignancies: a prospective phase II study of the Arbeitsgemeinschaft Gynäekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and Kommission Uterus (AGO-K-Ut).
    du Bois A, Pfisterer J, Burchardi N, Loibl S, Huober J, Wimberger P, Burges A, Stähle A, Jackisch C, Kölbl H, Arbeitsgemeinschaft Gynäekologische Onkologie Studiengruppe Ovarialkarzinom, Kommission Uterus.
    Gynecol Oncol; 2007 Dec 15; 107(3):518-25. PubMed ID: 17910981
    [Abstract] [Full Text] [Related]

  • 19. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM).
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206
    [Abstract] [Full Text] [Related]

  • 20. Addition of epirubicin as a third drug to carboplatin-paclitaxel in first-line treatment of advanced ovarian cancer: a prospectively randomized gynecologic cancer intergroup trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group and the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens.
    du Bois A, Weber B, Rochon J, Meier W, Goupil A, Olbricht S, Barats JC, Kuhn W, Orfeuvre H, Wagner U, Richter B, Lueck HJ, Pfisterer J, Costa S, Schroeder W, Kimmig R, Pujade-Lauraine E, Arbeitsgemeinschaft Gynaekologische Onkologie, Ovarian Cancer Study Group, Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens.
    J Clin Oncol; 2006 Mar 01; 24(7):1127-35. PubMed ID: 16505432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.